/Imec And NeuroGyn AG Collaborate On Advanced Neurostimulation Device For Pelvic Nerve Disorders

Press release

Imec And NeuroGyn AG Collaborate On Advanced Neurostimulation Device For Pelvic Nerve Disorders

ITF HEALTH

October 13, 2021 | Virtual event - Revolutionizing Research to Curb Pandemics

Discover more

Imec and Neurogyn AG collaborate on advanced neurostimulation device for pelvic nerve disorders. The new solution aims at prolonging the lifetime of the device while lowering its cost, making it suitable at the point of need.

About imec

Imec is a world-leading research and innovation center in nanoelectronics and digital technologies. Imec leverages its state-of-the-art R&D infrastructure and its team of more than 5,000 employees and top researchers, for R&D in advanced semiconductor and system scaling, silicon photonics, artificial intelligence, beyond 5G communications and sensing technologies, and in application domains such as health and life sciences, mobility, industry 4.0, agrifood, smart cities, sustainable energy, education, … Imec unites world-industry leaders across the semiconductor value chain, Flanders-based and international tech, pharma, medical and ICT companies, start-ups, and academia and knowledge centers. Imec is headquartered in Leuven (Belgium), and has research sites across Belgium, in the Netherlands, Taiwan and the USA, and offices in China, India and Japan. In 2020, imec's revenue (P&L) totaled 680 million euro.

Further information on imec can be found at www.imec-int.com.

Imec is a registered trademark for the activities of imec International (IMEC International, a legal entity set up under Belgian law as a “stichting van openbaar nut”), imec Belgium (IMEC vzw supported by the Flemish Government), imec the Netherlands (Stichting IMEC Nederland),  imec Taiwan (IMEC Taiwan Co.), imec China (IMEC Microelectronics (Shanghai) Co. Ltd.), imec India (IMEC India Private Limited), imec San Francisco (IMEC Inc.) and imec Florida (IMEC USA Nanoelectronics Design Center Inc.).

About NeuroGyn AG

NeuroGyn AG is a Swiss based Medtec Company developing and marketing new innovative solutions in the domain of neurotechnology, which are the result of modern R&D based on the last findings in Neuropelveology.

NeuroGyn is the first company in the world developing a proprietary pacemaker and corresponding implantation apparatus for intrapelvic neuromodulation. The capability to implant a pacemaker within the body to all pelvic nerves opens the door to a whole new area of humanity. NeuroGyn has the potential to revolutionize standard treatment options for pelvic organ disorders and to introduce pelvic neuromodulation to women’s health and neuropelveology – a new groundbreaking discipline in Medicine dealing with the pathologies of the intrapelvic nerves.

Contact: Prof. Prof. (DK) Prof hc (China) Dr. med. M. Possover, MD, PhD (Founder & CSO) // +41 44 520 36 00 // m.possover@possover.com

About imec the Netherlands

Imec the Netherlands, part of imec International, is located in Eindhoven and is part of Holst Centre, an independent open-innovation R&D centre by imec and TNO. Imec the Netherlands has a longstanding expertise and excellent track record in low power wireless sensor solutions and flexible electronics: the building blocks to create an easy-to-use Internet of Things. The Intuitive Internet of Things (I2oT) department, which is part of this project, focuses on next generation wireless transducer solutions and is active in technology development for ultralow-power radio and digital signal processing, micro-power generation, storage and management, and sensor and actuator technology. Based on these building blocks, imec the Netherlands builds system solutions in the area of health and lifestyle that contain embedded algorithms and neuromorphic circuits to address specific applications.